Fingerprint
Dive into the research topics of 'A phase I study of the combination of rituximab and ipilimumab in patients with relapsed/ refractory B-cell lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I study of the combination of rituximab and ipilimumab in patients with relapsed/ refractory B-cell lymphoma
Joseph M. Tuscano, Emanual Maverakis, Susan Groshen, Denice Tsao-Wei, Guillaume Luxardi, Alexander A. Merleev, Anne Beaven, John F. DiPersio, Leslie Popplewell, Robert Chen, Mark Kirschbaum, Mark A. Schroeder, Edward M. Newman
Research output: Contribution to journal › Article › peer-review
16
Scopus
citations